NBP in Patients With Moyamoya Disease of High Risk for Ischemic Cerebrovascular Events
A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 450 participants.
Also called NCT04205578
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose diagnostic
- Phase
- Phase 3
- Enrolled
- 450 participants
- Sponsor
- yuanli Zhao
- Registry
-
NCT04205578
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Unknown status
Technical summary
Registry record NCT04205578. Randomized; single masking; primary purpose diagnostic. Start 2020-01 (anticipated); primary completion 2022-12-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- NBP in Patients With Moyamoya Disease of High Risk for Ischemic Cerebrovascular Events
- Acronym
- NICE-MMD
- Condition
- Moyamoya Disease
- Condition
- Ischemic Cerebral Infarction
- Condition
- Ischemic Stroke
- Condition
- Ischemic Cerebrovascular Accident
- Condition
- Transient Ischemic Attack
- Intervention (Drug)
- dl-3-n-butylphthalide (NBP)
- Intervention (Drug)
- Normal Saline 0.9% Infusion Solution
- Lead sponsor
- yuanli Zhao
- Collaborator
- Peking University International Hospital
Record details
- Record id
cardio:ct-nct04205578- Content hash
7fb0c2800ad3be7e309b1fed9d77871530ec6c33401bcc138e1be5284bf24dee